首页> 外文期刊>Cancer gene therapy >LncRNA KCNQ1OT1 regulates the invasion and migration of hepatocellular carcinoma by acting on S1PR1 through miR-149
【24h】

LncRNA KCNQ1OT1 regulates the invasion and migration of hepatocellular carcinoma by acting on S1PR1 through miR-149

机译:LNCRNA KCNQ1OT1通过在MIR-149上作用于S1PR1来调节肝细胞癌的侵袭和迁移

获取原文
           

摘要

The aim of this study was to investigate the effect of lncRNA KCNQ1OT1 on HCC and to explore the possible underlying mechanisms. The expression levels of KCNQ1OT1, miR-149 and S1PR1 were detected by qRT-PCR assay. A dual luciferase reporter assay was used to detect the interaction between KCNQ1OT1 and miR-149, as well as miR-149 and S1PR1. The interaction between KCNQ1OT1 and miR-149 was further investigated by RNA pull-down assay. Wound healing assays and Transwell assays were carried out to determine cell migration and invasion. A xenograft tumour assay was used to validate the role of KCNQ1OT1 in vivo. KCNQ1OT1 and S1PR1 were significantly increased, but miR-149 was decreased in HCC cells. Luciferase reporter assays and RNA pull-down assays revealed that KCNQ1OT1 directly targeted miR-149. In addition, miR-149 bound to the 3'-UTR of S1PR1. Knockdown of KCNQ1OT1 or overexpression of miR-149 inhibited the invasion and migration of HCC cells. However, suppression of miR-149 could abrogate the effect of KCNQ1OT1 knockdown on the invasion and migration abilities of HCC cells. In vivo assays showed that KCNQ1OT1 knockdown suppressed tumour growth. This work suggests that lncRNA KCNQ1OT1 might act as a potential therapeutic target in HCC.
机译:本研究的目的是探讨LNCRNA KCNQ1OT1对HCC的影响,探讨可能的潜在机制。通过QRT-PCR测定检测KCNQ1OT1,miR-149和S1pr1的表达水平。使用双荧光素酶报告器测定检测KCNQ1OT1和MIR-149之间的相互作用,以及MIR-149和S1PR1。通过RNA下拉测定进一步研究KCNQ1OT1和MIR-149之间的相互作用。进行伤口愈合测定和Transwell测定以确定细胞迁移和侵袭。异种移植肿瘤测定用于验证KCNQ1OT1在体内的作用。 KCNQ1OT1和S1PR1显着增加,但MIR-149在HCC细胞中降低。荧光素酶报告器测定和RNA下拉测定显示,KCNQ101直接靶向miR-149。此外,miR-149与S1PR1的3'-UTR结合。 MIR-149的KCNQ1OT1或过表达的敲低抑制了HCC细胞的侵袭和迁移。然而,MIR-149的抑制可以消除KCNQ1OT1敲低对HCC细胞侵袭和迁移能力的影响。体内测定显示KCNQ1OT1敲低抑制肿瘤生长。这项工作表明,LNCRNA KCNQ1OT1可能是HCC中的潜在治疗目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号